The therapeutic and diagnostic potential of single-domain antibodies (SdAbs) is gaining increasing attention, primarily due to their compact size, strong binding affinity, and favorable biophysical properties. Despite these advantages, one of the key barriers to broader application is:
The ability to identify SdAb candidates with robust thermal stability.
Many conventional antibodies or binders tend to lose their structural integrity under high temperatures or during long-term storage, which compromises their functional performance in bioproduction, formulation, and clinical settings.
At Creative Biolabs, we have established a rigorous and highly efficient platform for discovering thermally stable SdAbs tailored for demanding applications. Our strategy takes advantage of the inherent heat tolerance of M13 bacteriophages, seamlessly integrating a thermal stress-based biopanning step into the traditional phage display workflow. This innovative screening approach not only enriches for binders with superior affinity and specificity but also ensures that the final candidates demonstrate exceptional resilience under challenging physiological and manufacturing conditions.
By subjecting antibody libraries to elevated temperatures during affinity selection, we demonstrate the ability to enrich for and isolate SdAbs that retain antigen-binding activity with melting temperatures (Tm) elevated by over 10°C compared to conventionally selected binders. These thermostable SdAbs are ideally suited for applications requiring enhanced developability, including high-yield recombinant production, and for targeting difficult epitopes on complex membrane proteins.
Table 1 Biophysical and Functional Comparison of Antibody Formats
| Feature | Conventional Antibodies (mAbs) | Single-Domain Antibodies (SdAbs) |
| Structure | Heterotetramer (2 heavy, 2 light chains) | Monomer (single VHH domain) |
| Size | ~150 kDa | ~15 kDa |
| Stability | Variable, less thermostable | Generally high, superior stability |
| Solubility | Variable, prone to aggregation | Generally high |
| Epitope Access | Often binds flatter surfaces | Can access cryptic epitopes, clefts, and grooves |
| Tissue Penetration | Lower | Enhanced |
| Production System | Complex mammalian cell systems | Efficient microbial systems (E. coli, yeast) |
| Lot-to-Lot Consistency | Variable | High |
Our Thermal Stable SdAb Discovery Service follows a meticulously optimized workflow to ensure the isolation of high-quality candidates. The process begins with the construction of a diverse SdAb library, this library is then used as the starting material for our core screening protocol, which is comprised of the following key steps:
| SdAb Library Construction | |
|
Immune-derived sdAb libraries (llamas, alpacas, and camels) Naïve/germline-diverse libraries Fully synthetic libraries Ready-to-use premade libraries |
|
Choosing Creative Biolabs for your Thermal Stable SdAb discovery project offers distinct advantages that accelerate research and enhance the quality of your final biologic candidates:
Our unique thermal biopanning protocol yields SdAbs with a proven increase in thermal stability, ensuring a pipeline of highly robust molecules.
We provide candidates with a high level of both specificity and affinity, validated through comprehensive screening and biophysical characterization.
We offer diverse, tailored biopanning strategies to optimize the selection process for each unique antigen and research objective.
Our team of professional, Ph.D. level scientists bring extensive expertise in phage display and antibody engineering to every project.
Our platform is designed for high sensitivity and high throughput, which translates to a fast turnover time from project initiation to candidate delivery.
Clients retain full ownership of the intellectual property, including all identified sequences and developed antibodies, providing complete freedom for downstream development and commercialization.
Creative Biolabs Thermal Stable SdAb Discovery Service merges phage display precision with thermal resilience engineering, empowering researchers to overcome the limitations of conventional antibodies. By coupling unparalleled technical expertise with a client-centric approach, we deliver solutions that redefine stability in antibody-based applications.
For collaboration inquiries or project consultations, contact us at Online Inquiry box on the right.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.